Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Savi R Shishkov in
Google Scholar
PubMed
Università “Federico II” di Napoli, Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Naples, Italy
Search for other papers by Luigi Tuccillo in
Google Scholar
PubMed
Search for other papers by Violeta M Iotova in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Iris CM Pelsma in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology & Metabolism, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Alberto M Pereira in
Google Scholar
PubMed
Adult Chair of MTG Pituitary of Endo-ERN
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
Search for other papers by the Endo-ERN Reference Centers of the Main Thematic Group: Hypothalamic and Pituitary Conditions, Endo-ERN Pituitary Transition of Care Study Group in
Google Scholar
PubMed
1 , indicated that hypopituitarism was managed by all RCs and physicians, while acromegaly was managed by the fewest RCs ( N = 15/30, 50%) and physicians ( n = 18/46, 39%). In 13 (43%) of the responding RCs and by 10 (22%) of the responding
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Tricia Tan in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Katharine Lazarus in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
interrogated a regionally held UK database containing information on patients with acromegaly, which included 178 patients receiving hydrocortisone for hypoadrenalism ( 9 ). Patients with acromegaly had an increased SMR of 1.7 compared to the general population
Search for other papers by Alessandro Ciresi in
Google Scholar
PubMed
Search for other papers by Stefano Radellini in
Google Scholar
PubMed
Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed
Search for other papers by Maria Grazia Mineo in
Google Scholar
PubMed
Search for other papers by Carla Giordano in
Google Scholar
PubMed
.2337/dbib8-1478 ) 18957530 10.2337/dc08-1478 22 Colao A Amato G Pedroncelli AM Baldelli R Grottoli S Gasco V Petretta M Carella C Pagani G Tambura G , Gender- and age-related differences in the endocrine parameters of acromegaly
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jesper Krogh in
Google Scholar
PubMed
Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Peter Plomgaard in
Google Scholar
PubMed
Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Ruth Frikke-Schmidt in
Google Scholar
PubMed
Search for other papers by Sten Velschow in
Google Scholar
PubMed
Department of Pediatrics, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark
Search for other papers by Jesper Johannesen in
Google Scholar
PubMed
Search for other papers by Linda Maria Hilsted in
Google Scholar
PubMed
Search for other papers by Malene Schrøder in
Google Scholar
PubMed
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Introduction In an everyday endocrine setting, the dynamic response of hormones is assessed for the diagnosis and evaluation of several conditions such as adrenal insufficiency ( 1 ), acromegaly ( 2 ), and growth hormone deficiency ( 3
Université Lyon 1, Villeurbanne, France
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Centre de Biologie et Pathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
INSERM U1052, CNRS, UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed
Search for other papers by Véronique Lapras in
Google Scholar
PubMed
Search for other papers by Véronique Raverot in
Google Scholar
PubMed
Search for other papers by Eudeline Alix in
Google Scholar
PubMed
Université Lyon 1, Villeurbanne, France
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
INSERM U1052, CNRS, UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Service de Neurochirurgie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Search for other papers by Emmanuel Jouanneau in
Google Scholar
PubMed
Université Lyon 1, Villeurbanne, France
INSERM U1052, CNRS, UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Search for other papers by Gérald Raverot in
Google Scholar
PubMed
Université Lyon 1, Villeurbanne, France
INSERM U1052, CNRS, UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France
Search for other papers by Hélène Lasolle in
Google Scholar
PubMed
Gu F Shen CC Gadelha M Fleseriu M van der Lely AJ Farrall AJ Hermosillo Reséndiz K , et al . Pasireotide versus octreotide in acromegaly: a head-to-head superiority study . Journal of Clinical Endocrinology and Metabolism 2014 99
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
with acromegaly from four electronic databases showed that arginine and proline were the most altered pathways ( 48 ). Therefore, we assumed that the abnormal GH levels might be associated with arginine metabolism, thus arginine metabolism was well
Search for other papers by Liza Das in
Google Scholar
PubMed
Search for other papers by Kim Vaiphei in
Google Scholar
PubMed
Search for other papers by Ashutosh Rai in
Google Scholar
PubMed
Search for other papers by Chirag Kamal Ahuja in
Google Scholar
PubMed
Search for other papers by Paramjeet Singh in
Google Scholar
PubMed
Search for other papers by Ishani Mohapatra in
Google Scholar
PubMed
Search for other papers by Rajesh Chhabra in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
Search for other papers by Bishan Dass Radotra in
Google Scholar
PubMed
Green Templeton College, University of Oxford, Oxford, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Pinaki Dutta in
Google Scholar
PubMed
(acromegaly or Cushing’s syndrome) ( 5 , 6 , 7 ); however, posterior pituitary dysfunction (diabetes insipidus (DI)) is virtually never seen prior to surgery ( 4 ). PPTs are usually seen as suprasellar or sellar-suprasellar masses with no pathognomonic
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Search for other papers by Chiara Sabbadin in
Google Scholar
PubMed
Search for other papers by Miriam Dalla Costa in
Google Scholar
PubMed
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Corrado Betterle in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
Endocrinology and Metabolism 2016 101 3888 – 3921 . ( https://doi.org/10.1210/jc.2016-2118 ) 10.1210/jc.2016-2118 4 Ceccato F Lizzul L Zilio M Barbot M Denaro L Emanuelli E Alessio L Rolma G Manara R Saller A , et al . Medical treatment for acromegaly
Search for other papers by Kennett Sprogøe in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by David B Karpf in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
regurgitant valvular heart disease in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 71 – 75 . ( doi:10.1210/jc.2003-030849 ) 10.1210/jc.2003-030849 52 Melmed S. Acromegaly pathogenesis and treatment. Journal of Clinical
Search for other papers by Reem Al Argan in
Google Scholar
PubMed
Search for other papers by Abdulaziz Ramadhan in
Google Scholar
PubMed
Search for other papers by Ramanakumar V Agnihotram in
Google Scholar
PubMed
Search for other papers by Jeffrey Chankowsky in
Google Scholar
PubMed
Search for other papers by Juan Rivera in
Google Scholar
PubMed
Bonneville JF . T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective . Pituitary 2017 20 116 – 120 . ( https://doi.org/10.1007/s11102-017-0788-8 ) 16 Mukai K